Neoadjuvant chemoradiation therapy for resectable esophago-gastric adenocarcinoma: a meta-analysis of randomized clinical trials

[1]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[2]  J. Ferlay,et al.  Global incidence of oesophageal cancer by histological subtype in 2012 , 2014, Gut.

[3]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.

[4]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[5]  D. Richel,et al.  Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  M. Ychou,et al.  Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data. , 2013, European journal of cancer.

[7]  C. Willett,et al.  Preoperative chemoradiotherapy for locally advanced gastric cancer , 2013, Radiation Oncology.

[8]  K. Sugano,et al.  Digestive cancer management in Asia: Position statements: A report on GI Oncology Summit in 2011 , 2012, Journal of gastroenterology and hepatology.

[9]  E W Steyerberg,et al.  Preoperative chemoradiotherapy for esophageal or junctional cancer. , 2012, The New England journal of medicine.

[10]  C. Montagut,et al.  Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  V. Gebski,et al.  Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. , 2011, The Lancet. Oncology.

[12]  Jong Hoon Kim,et al.  Phase I study of preoperative chemoradiation with s-1 and oxaliplatin in patients with locally advanced resectable rectal cancer. , 2011, International journal of radiation oncology, biology, physics.

[13]  A. Barbour,et al.  Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial. , 2011, European journal of cancer.

[14]  J. Ji,et al.  [Surgical treatment results and prognostic analysis of 514 cases with gastroesophageal junction carcinoma]. , 2010, Zhonghua wai ke za zhi [Chinese journal of surgery].

[15]  C. Mariette,et al.  Surgery alone versus chemoradiotherapy followed by surgery for localized esophageal cancer: Analysis of a randomized controlled phase III trial FFCD 9901. , 2010 .

[16]  M. Stuschke,et al.  Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  T. Kubota,et al.  Phase II study of chemoradiotherapy with S-1 and low-dose cisplatin for inoperable advanced gastric cancer. , 2008, International journal of radiation oncology, biology, physics.

[18]  D. Sugarbaker,et al.  Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  M. Sydes,et al.  Practical methods for incorporating summary time-to-event data into meta-analysis , 2007, Trials.

[20]  Val Gebski,et al.  Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. , 2007, The Lancet. Oncology.

[21]  J. Wydmański,et al.  The tolerance and efficacy of preoperative chemoradiotherapy followed by gastrectomy in operable gastric cancer, a phase II study. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  J. Ajani,et al.  Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  J. V. van Lanschot,et al.  Differences and similarities of adenocarcinomas of the esophagus and esophagogastric junction , 2005, Journal of surgical oncology.

[24]  V. Gebski,et al.  Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. , 2005, The Lancet. Oncology.

[25]  J. Ajani,et al.  Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  A. Venturi,et al.  Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis , 2004, Gut.

[27]  Paula R Williamson,et al.  Aggregate data meta‐analysis with time‐to‐event outcomes , 2002, Statistics in medicine.

[28]  J. Ajani,et al.  A Pilot Study of Preoperative Chemoradiotherapy for Resectable Gastric Cancer , 2001, Annals of Surgical Oncology.

[29]  M. Iannettoni,et al.  Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  M. Parmar,et al.  Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. , 1998, Statistics in medicine.

[31]  W. Yin,et al.  Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)--report on 370 patients. , 1998, International journal of radiation oncology, biology, physics.

[32]  M. Posner,et al.  Preoperative chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction. , 1998, The cancer journal from Scientific American.

[33]  J P Vandenbroucke,et al.  Bias in meta-analysis detected by a simple, graphical test , 1998 .

[34]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[35]  T. Walsh,et al.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. , 1996, The New England journal of medicine.

[36]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[37]  D. Chamberlain.  Irradiation of Gastric Cancer , 1947, British medical journal.

[38]  A. Shorter,et al.  Irradiation of Gastric Cancer* , 1947, The British journal of radiology.

[39]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[40]  S. DeMeester.  Adenocarcinoma of the Esophagus and Cardia: A Review of the Disease and Its Treatment , 2006, Annals of Surgical Oncology.

[41]  A. Livingstone,et al.  Neoadjuvant Treatment for Resectable Cancer of the Esophagus and the Gastroesophageal Junction: A Meta-Analysis of Randomized Clinical Trials , 2003, Annals of Surgical Oncology.

[42]  C. Mcginn,et al.  The mechanism of action of radiosensitization of conventional chemotherapeutic agents. , 2003, Seminars in radiation oncology.

[43]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.